Cell Lymphomas: Recent Phase III - CD20×CD3 Bispecific Antibodies in Relapsed/Refractory B Evidence Durability, and Safety

Arwa S. Arebee

· 0 citations · 17 references

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.